Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Tessari Eben exercised options for 2,726 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Apr 7, 2026 · Filed Apr 8, 2026
On Apr 7, 2026, Tessari Eben (CHIEF STRATEGY OFFICER) exercised options for 2,726 Kiniksa Pharmaceuticals International, Plc shares, leaving 23,130 shares. Filed Apr 8, 2026 (Form 4).
- Options exercised
- 2,726 shares
- Holding after
- 23,130 shares
- Trading plan
- No
- Role
- CHIEF STRATEGY OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Class A Ordinary Share | Option exercise | 2,726 | 23,976 | Direct | |
| Apr 7, 2026 | Class A Ordinary Share | Shares withheld for tax | 846 | US$48.94 | 23,130 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Tessari Eben
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Tessari Eben · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026